Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 7, 2015; 21(37): 10621-10635
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10621
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10621
Table 3 Recommendations
| Food | Evidence level (good, moderate, poor) | Dose |
| Oily fish/fish oil (Omega-3 PUFAs) | Moderate (NAFLD) | ≥ 0.83 g/d n-3 or 2 servings of oily fish/wk (3.5 oz/serve)1 |
| Good (Metabolic disease) | Coronary artery disease (CAD): 1 g/d | |
| Hypertriglyceridemia: 2-4 g/d | ||
| Coffee | Moderate (NAFLD) | ≥ 3 cups per day1 |
| Moderate (Metabolic disease) | ||
| Nuts | Moderate (NAFLD) | 100 g (handful)/d1 |
| Good (Metabolic disease) | ||
| Tea | Poor (NAFLD) | ≥ 5-10 cups per day1 |
| Poor (Metabolic disease) | ||
| Red wine | Poor (NAFLD) | 100-200 mL/d1 |
| Moderate (Metabolic disease) | ||
| Avocado | Poor (NAFLD) | 1/2 avocado (68 g)/per day1 |
| Moderate (Metabolic disease) | ||
| Olive oil | Poor (NAFLD) | Consumption as part of Mediterranean diet < 20 g/d1 |
| Moderate (Metabolic disease) |
- Citation: Gupta V, Mah XJ, Garcia MC, Antonypillai C, van der Poorten D. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World J Gastroenterol 2015; 21(37): 10621-10635
- URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10621.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i37.10621